| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.6 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |